U.S. markets close in 1 hour 36 minutes

Elevance Health Inc. (ELV)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
467.45+13.21 (+2.91%)
As of 02:23PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Fast Stochastic

Fast Stochastic

Previous Close454.24
Bid467.16 x 1000
Ask467.49 x 900
Day's Range453.90 - 468.75
52 Week Range363.68 - 533.68
Avg. Volume858,319
Market Cap112.19B
Beta (5Y Monthly)0.89
PE Ratio (TTM)18.73
EPS (TTM)24.96
Earnings DateOct 18, 2022 - Oct 24, 2022
Forward Dividend & Yield5.12 (1.13%)
Ex-Dividend DateSep 08, 2022
1y Target Est559.38
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
4% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for ELV

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Elevance Health, Inc.
    Technical Assessment: Neutral in the Intermediate-TermHave stock indices come far enough to put the bear to bed? The media is doing what they do, and calling the recent stock advance "unprecedented." Oh really? We will examine two time periods: one off "the" closing low on June 16 (39-day) and the other when stocks started shooting higher after the low on July 14 (21-day).
    Fair Value
    Economic Moat
    2 months agoArgus Research
View more
  • Reuters

    Anthem must face U.S. government lawsuit alleging Medicare Advantage fraud

    A federal judge ordered Anthem Inc to face a U.S. government lawsuit claiming it submitted inaccurate diagnosis data, enabling the health insurer to fraudulently collect tens of millions of dollars in annual overpayments from Medicare. In a decision released on Monday, U.S. District Judge Andrew Carter in Manhattan said the total alleged overpayment to Anthem appeared to be well over $100 million, making the government's financial costs "substantial and not merely administrative." The Department of Justice lawsuit filed in March 2020 stemmed from Anthem's operation of dozens of Medicare Part C plans, also known as Medicare Advantage, a privatized system that insures Americans who opt out of traditional Medicare.

  • Business Wire

    Elevance Health Responds to Florida Communities Affected by Hurricane Ian

    INDIANAPOLIS, October 03, 2022--As part of its commitment to communities across the U.S., Elevance Health and its philanthropic arm Elevance Health Foundation provides support relief efforts to assist those affected by Hurricane Ian and other natural disasters.

  • Simply Wall St.

    Those who invested in Elevance Health (NYSE:ELV) five years ago are up 150%

    The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, if...